Physician profile

Kevin L Sullivan

Vascular & Interventional Radiology · Decatur, GA

NPI 1447276225

$1,004.67

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

See the full distribution for Vascular & Interventional Radiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$97.45

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Merit Medical Systems INC $647.50 2020
Bard Peripheral Vascular, INC. $219.77 2019-2021
Medtronic, INC. $80.32 2023 In.Pact Admiral
Csl Behring $23.55 2022
Boston Scientific Corporation $17.13 2023 Watchman Flx
Lemaitre Vascular, INC. $16.40 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Kevin L Sullivan

$1,004.67

in general payments reported 2019-2025

Years
2019-2023
Top company
Merit Medical Systems INC

https://glasscript.com/doctor/337625/kevin-l-sullivan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.